Approval · Notice of Compliance 3567 · 2003
ALDACTAZIDE: Notice of Compliance 3567
Issued September 15, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3567
- Date
- September 15, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Aldosterone antagonist with a diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDACTAZIDE | 00180408 | Cancelled Post Market |
| ALDACTAZIDE | 00594377 | Cancelled Post Market |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 25 MG per TAB
- SPIRONOLACTONE 25 MG per TAB
- HYDROCHLOROTHIAZIDE 50 MG per TAB
- SPIRONOLACTONE 50 MG per TAB